ReNerve Limited (ASX:RNV) has entered into a strategic partnership with NetCentrix Ventures to expand into the high-growth Indian nerve repair market. This partnership will focus on obtaining regulatory approval and developing a commercialization strategy for the NervAlign® Nerve Cuff product. With the Indian nerve repair sector currently valued at US$115M and projected to double by 2030, this collaboration provides ReNerve access to a rapidly growing market.<br/><br/>India offers a significant opportunity due to its expanding healthcare infrastructure, investments in advanced surgical capabilities, and increasing incidence of nerve injuries. Dr. Julian Chick, CEO of ReNerve, highlighted the strategic fit between the NervAlign® technology and the needs of the Indian healthcare system. This partnership complements ReNerve's existing international agreements and strengthens its global commercialization framework.<br/><br/>The NervAlign® Nerve Cuff, designed to protect and regenerate nerves during healing after surgery, offers a cost-effective solution with clinical benefits. Investors interested in learning more about this partnership and ReNerve's expansion strategy can reach out to us for further information. We welcome any questions or inquiries regarding this exciting development.